The management of low-stage non-seminomatous germ cell tumors

Main Article Content

Louise Lim (1*), Thomas Powles (2)

1 Department of Medical Oncology, Barts Cancer Institute, QMUL, Experimantal Cancer Med St. Bartholomew’s Hospital London, United Kingdom.
2 Department of Medical Oncology, Barts Cancer Institute, QMUL, Experimantal Cancer Med St. Bartholomew’s Hospital London, United Kingdom.
(*) Corresponding Author:
Louise Lim
FarahLouise.Lim@bartshealth.nhs.uk

Abstract

The prognosis of patients with stage I non-seminomatous germ cell tumors is in general very good. However, a large number of patients relapse with metastatic disease after orchidectomy Therefore, adjuvant treatment, in the form of either chemotherapy or retroperitoneal dissection is recommended, although active surveillance has been found to be as good a way of treating these patients with overall excellent results.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

How to Cite
Lim, L., & Powles, T. (2012). The management of low-stage non-seminomatous germ cell tumors. Oncology Reviews, 6(2), e19. https://doi.org/10.4081/oncol.2012.e19